Oil at $60 will mean restructuring for some U.S. shale producers, a Deutsche Bank analyst said. But will it become a bigger problem?» Read More
Sarepta Therapeutics got the go-ahead to file for approval of its experimental drug for Duchenne muscular dystrophy.
CNBC's Meg Tirrell reports on a new scientific discovery for the more than $1.7 billion U.S. business of in vitro fertilization. Robert Frank provides insight.
CNBC's John Harwood reflects on the last 25 years in D.C., as well as Texas Gov. Rick Perry's debate gaffe.
Both Monaco and Miami have soaring real estate prices. CNBC's Robert Frank reports the super rich are really transforming Miami.
Lululemon is having its first analyst day since its new CEO took over in January. Stacey Widlitz, CNBC retail analyst, provides perspective.
American oil companies are telling our U.S. state department they don't want a full-scale financial sanctions war, explains CNBC's Larry Kudlow. He makes the case for raising the value of the U.S. Dollar by 15 percent which he says will kill the price of oil.
CNBC's Steve Sedgwick provides an update from Geneva, where Ukraine talks are taking place.
Digging into what's really going on in the current trading action, with Art Hogan, Wunderlich Securities.
CNBC's Herb Greenberg explains why he thinks IBM should have sold off more today.
CNBC looks back on Mandy Drury's years with "Street Signs."
CNBC's Mary Thompson reports on the dark side of bitcoin.
Discussing the potential impact to gun sales after former NYC Mayor Mike Bloomberg announced he is spending $50 million on a gun safety group, with Brian Rafn, Morgan Dempsey Capital Management.
Hunter Keay of Wolfe Research, says there is no fundamental reason the airlines are off from their recent highs, and shares his top picks.
Many analysts still believe Twitter is overvalued after the stock's surge on its purchase of social data firm Gnip. CNBC's Morgan Brennan reports.
Rounding up all the earnings news investors should be keeping an eye on, including Goldman Sachs and Morgan Stanley preparing to report Q1 data on Thursday, with CNBC's Melissa Lee, Kate Kelly and Dominic Chu.
Sam Isaly, OrbiMed Advisors, shares his positive outlook for Regeneron, and what he thinks about Amgen's pipeline.
Neil Doshi, CRT Capital internet analyst, makes the bull case for Yahoo sans Alibaba.
CNBC's Rick Santelli provides insight on the action in the yield curve after Federal Reserve Chair Janet Yellen commented on inflation.
Discussing the Fed's current outlook of the U.S. economy, with Anika Khan, Wells Fargo Securities senior economist.
CNBC's Steve Liesman reports the highlights of the Fed's Beige Book.